awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36716222-1B949D4C-B15F-4C0D-A6ED-D37FDCCB9F72
Q36716222-1B949D4C-B15F-4C0D-A6ED-D37FDCCB9F72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36716222-1B949D4C-B15F-4C0D-A6ED-D37FDCCB9F72
Safety of Anti-Diabetic Therapies on Bone.
P2860
Q36716222-1B949D4C-B15F-4C0D-A6ED-D37FDCCB9F72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36716222-1B949D4C-B15F-4C0D-A6ED-D37FDCCB9F72
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66e5eea78bdf00b0df4a9dc3264d27ae7b9089f3
P2860
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.